These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20608899)

  • 1. Fanconi anaemia, BRCA2 and familial considerations - follow up on a previous case report.
    Bodd TL; Van Ghelue M; Eiklid K; Ruud E; Møller P; Mæhle L
    Acta Paediatr; 2010 Nov; 99(11):1741-3. PubMed ID: 20608899
    [No Abstract]   [Full Text] [Related]  

  • 2. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The twists and turns in BRCA's path.
    Couzin J
    Science; 2003 Oct; 302(5645):591-3. PubMed ID: 14576418
    [No Abstract]   [Full Text] [Related]  

  • 4. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
    Reid S; Renwick A; Seal S; Baskcomb L; Barfoot R; Jayatilake H; Pritchard-Jones K; Stratton MR; Ridolfi-Lüthy A; Rahman N; ;
    J Med Genet; 2005 Feb; 42(2):147-51. PubMed ID: 15689453
    [No Abstract]   [Full Text] [Related]  

  • 5. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedicine. D-Day for BRCA2.
    Witt E; Ashworth A
    Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility pathways in Fanconi's anemia and breast cancer.
    D'Andrea AD
    N Engl J Med; 2010 May; 362(20):1909-19. PubMed ID: 20484397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
    Leegte B; van der Hout AH; Deffenbaugh AM; Bakker MK; Mulder IM; ten Berge A; Leenders EP; Wesseling J; de Hullu J; Hoogerbrugge N; Ligtenberg MJ; Ardern-Jones A; Bancroft E; Salmon A; Barwell J; Eeles R; Oosterwijk JC
    J Med Genet; 2005 Mar; 42(3):e20. PubMed ID: 15744030
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family.
    Salgado J; Aramendía JM; Gutierrez C; Gil C; Robles M; García-Foncillas J
    Breast Cancer Res Treat; 2010 May; 121(1):219-20. PubMed ID: 19288190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial cancer on a Scottish island.
    Hill RD
    Br Med J; 1976 Aug; 2(6032):401-2. PubMed ID: 1065448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
    Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
    Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anaemia genes and susceptibility to cancer.
    Mathew CG
    Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A growing network of cancer-susceptibility genes.
    Venkitaraman AR
    N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
    [No Abstract]   [Full Text] [Related]  

  • 16. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
    Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2-induced graft-versus-leukemia for the treatment of AML in a BRCA2 Fanconi anemia patient.
    Yeo CJ; Gilman AL
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e78-80. PubMed ID: 23619121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.